Eptifibatide
FDA Approved: * June 5, 2015Pharm Company: * TEVA PHARMS USA
Category: Intravenous (IV) Therapy
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Eptifibatide Overview
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a disintegrin protein (P22827) found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eptifibatide
Recent Eptifibatide Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Eptifibatide
- Injection: 0.75mg/ml, 2mg/ml, 75mg/100ml
NDC Database Records for Eptifibatide: (31 results)
Showing the first 20, Sorted by National Drug Code- 0338-9558 Eptifibatide 75 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
- 0338-9559 Eptifibatide 200 mg/100ml Intravenous Injection by Baxter Healthcare Corporation
- 0703-1165 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
- 0703-1179 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
- 14335-070 Eptifibatide 2 mg/ml Intravenous Injection by Hainan Poly Pharm. Co., Ltd.
- 14335-071 Eptifibatide .75 mg/ml Intravenous Injection by Hainan Poly Pharm. Co., Ltd.
- 16729-259 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
- 16729-260 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
- 17478-902 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Akorn, Inc.
- 17478-903 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Akorn, Inc.
- 25021-408 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
- 25021-409 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
- 55150-218 Eptifibatide 75 mg/100ml Intravenous Injection by Auromedics Pharma LLC
- 55150-219 Eptifibatide 20 mg/10ml Intravenous Injection by Auromedics Pharma LLC
- 55150-220 Eptifibatide 200 mg/100ml Intravenous Injection by Auromedics Pharma LLC
- 59651-012 Eptifibatide 75 mg/100ml Intravenous Injection by Aurobindo Pharma Limited
- 59651-013 Eptifibatide 20 mg/10ml Intravenous Injection by Aurobindo Pharma Limited
- 59651-014 Eptifibatide 200 mg/100ml Intravenous Injection by Aurobindo Pharma Limited
- 62147-0600 Eptifibatide 2 mg/ml Intravenous Injection, Solution by Usv Private Limited
- 62147-0601 Eptifibatide .75 mg/ml Intravenous Injection, Solution by Usv Private Limited
- 11 more results ...
Other drugs which contain Eptifibatide or a similar ingredient: (1 result)
- INTEGRILIN Eptifibatide1 discussion